What are the side effects of Qfitlia (Fitusiran)?

As a new type of anticoagulant treatment drug, Qfitlia (Fitusiran) has a significant effect in preventing bleeding events in patients with hemophilia A or B, but its side effects cannot be ignored. First, Qfitlia comes with a boxed warning of serious adverse reactions, especially events related to thrombosis. This means that during treatment, patients may be at risk of venous thrombosis, pulmonary embolism, etc., especially in patients with other risk factors for thrombosis. This risk requires careful assessment prior to use and close monitoring during treatment.

In addition, acute and recurrent gallbladder disease is also an important side effect of Qfitlia. Patients may develop related symptoms such as cholecystitis, which may require additional medical intervention. Common adverse reactions include viral infections, nasopharyngitis and bacterial infections, with the incidence of these reactions exceeding 10%. These infections may affect the patient's daily life and overall health, so protective measures should be taken during treatment to reduce the risk of infection.

Qfitlia's liver toxicity is also a concern. Before starting treatment, the doctor will recommend a baseline liver test to understand the patient's liver function status. After initiation of treatment, and especially during dose adjustments, patients should undergo regular liver function monitoring, at least monthly for the first six months, to ensure that the liver is not adversely affected. Liver function abnormalities, if discovered, may require doctors to re-evaluate treatment options to protect the patient's health.

In summary, althoughQfitlia has shown good preventive effects in the treatment of hemophilia patients, its potential side effects and risks should not be underestimated. When using this drug, patients should be under the guidance of a professional doctor and conduct corresponding monitoring regularly to reduce the incidence of adverse reactions and ensure the safety and effectiveness of the treatment.

Reference materials:https://en.wikipedia.org/wiki/Fitusiran